Skip to content

The Outcomes of Sympathetic Cardiac Denervation on Postoperative Atrial Fibrillation After Cardiac Surgery, Randomized Controlled Trial

The Outcomes of Sympathetic Cardiac Denervation on Postoperative Atrial Fibrillation After Cardiac Surgery, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07811817
Enrollment
560
Registered
2026-09-10
Start date
2025-10-20
Completion date
2026-11-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Cardiac Surgery Atrial Fibrillation

Keywords

sympathetic cardiac denervation, post cardiac surgery atrial fibrillation

Brief summary

we compare the effect of cutting heart nerves in one group of patients with open heart surgery and other group without cutting oh development of disturbance of heart beat after surgery

Detailed description

identifying the outcome of sympathetic denervation on postoperative atrial fibrillation post cardiac surgery

Interventions

Before CPB initiation or during aortic cross-clamping, surgical denervation will be performed via meticulous blunt and sharp dissection. Target sites include \[e.g., complete transection/resection of the ligament of Marshall, fat pad mobilization at Waterston's groove, and epicardial neural pathway division\].

PROCEDUREStandard open-heart surgery without additional epicardial or fat pad dissection.

Standard open-heart surgery without additional epicardial or fat pad dissection.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Age ≥18 years scheduled for elective open-heart surgery via median sternotomy (CABG, valve repair/replacement, or combined procedures). \-

Exclusion criteria

* Preoperative permanent pacemaker or ICD. * Emergency surgery, active endocarditis, or severe hemodynamic instability. * Concomitant planned surgical ablation (e.g., Cox-Maze procedure) or left atrial appendage occlusion. * Preoperative use of antiarrhythmic drugs (AADs) other than beta-blockers within 5 half-lives of surgery.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of overall Post operative atrial fibrillation7th Post operative day or hospital discharge (whichever comes first).defined as any telemetry-documented or 12-lead ECG-confirmed episode of atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 continuous seconds through POD 7 or hospital discharge defined as any telemetry-documented or 12-lead ECG-confirmed episode of atrial fibrillation, atrial flutter, or atrial tachycardia lasting ≥30 continuous seconds through POD 7 or hospital discharge (whichever comes first
Incidence of persistent Post operative atrial fibrillation3 months posoperative(duration \>24 continuous hours or requiring urgent chemical/electrical cardioversion due to hemodynamic instability).

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026